OTCMKTS:TOMDF Todos Medical (TOMDF) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free TOMDF Stock Alerts 0.0001 0.00 (-50.00%) (As of 03/1/2024) Add Compare Share Share Today's Range0.00▼0.0050-Day Range N/A52-Week Range0.00▼0.00Volume14.50 million shsAverage Volume15.66 million shsMarket Capitalization$213,042.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Todos Medical alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Todos Medical Stock (OTCMKTS:TOMDF)Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.Read More TOMDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TOMDF Stock News HeadlinesApril 18, 2024 | americanbankingnews.comCritical Survey: Todos Medical (OTCMKTS:TOMDF) vs. Surmodics (NASDAQ:SRDX)April 5, 2024 | morningstar.comTodos Medical Ltd TOMDFApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.December 23, 2023 | finanznachrichten.deTodos Medical Ltd.: Todos Medical Announces Insolvency Proceedings in IsraelDecember 22, 2023 | finance.yahoo.comTodos Medical Announces Insolvency Proceedings in IsraelOctober 2, 2023 | investing.comTOMDF Historical DataSeptember 26, 2023 | finance.yahoo.comTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicAugust 30, 2023 | finance.yahoo.comTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 24, 2023 | finance.yahoo.comTodos Medical Ltd. (TOMDF)March 31, 2023 | finance.yahoo.comTodos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testingMarch 28, 2023 | proactiveinvestors.comTodos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic testMarch 28, 2023 | finance.yahoo.comTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsMarch 27, 2023 | finance.yahoo.comTodos Medical Begins Trading on the OTC Pink MarketplaceMarch 17, 2023 | proactiveinvestors.comTodos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patientsMarch 15, 2023 | finance.yahoo.comTodos Medical Supports Long COVID Awareness DayMarch 13, 2023 | finance.yahoo.comTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersFebruary 24, 2023 | proactiveinvestors.comTodos Medical releases corporate update around validation plan for PCR-based Avian Influenza testingFebruary 23, 2023 | proactiveinvestors.comTodos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rolloutFebruary 14, 2023 | proactiveinvestors.comTodos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humansFebruary 14, 2023 | finance.yahoo.comTodos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista DiagnosticsJanuary 21, 2023 | seekingalpha.comTOMDF Todos Medical Ltd.December 6, 2022 | finance.yahoo.comTodos Medical to Present at the RHK 2022 Disruptive Growth ConferenceNovember 29, 2022 | finance.yahoo.comTodos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022November 22, 2022 | finance.yahoo.comTodos Medical to Attend World Antiviral CongressNovember 16, 2022 | proactiveinvestors.comTodos Medical signs agreement to sell supplements via Affy Services’ Smart Automated Retail NetworkNovember 16, 2022 | finance.yahoo.comTodos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail NetworkSee More Headlines Receive TOMDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Todos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:TOMDF CUSIPN/A CIK1645260 Webtodosmedical.com Phone972732077259FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$12.23 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,408,130,000Free FloatN/AMarket Cap$140,813.00 OptionableNot Optionable Beta0.24 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Gerald E. Commissiong (Age 41)CEO, President & Director Comp: $465.27kMr. Daniel Hirsch (Age 55)CFO & Director Comp: $315.27kMr. Chris GrossVice President of OperationsDr. Jorge A. Leon Ph.D.Chief Science OfficerDr. Paula T. Trzepacz M.D.Chief Medical Officer of NeurologyDr. Joseph WeeManaging Director of SingaporeMs. Ilanit Halperin CPA (Age 53)Corporate Controller More ExecutivesKey CompetitorsVerisante TechnologyOTCMKTS:VRSEFPresbiaOTCMKTS:LENSFQuantRx BiomedicalOTCMKTS:QTXBMotus GINASDAQ:MOTSPeak BioNASDAQ:PKBOView All Competitors TOMDF Stock Analysis - Frequently Asked Questions How have TOMDF shares performed in 2024? Todos Medical's stock was trading at 0.00 at the start of the year. Since then, TOMDF stock has decreased by 50.0% and is now trading at 0.00. View the best growth stocks for 2024 here. How do I buy shares of Todos Medical? Shares of TOMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TOMDF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”AltimetryBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Todos Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
